KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) EBITDA (2016 - 2025)

Historic EBITDA for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to $619.0 million.

  • Bausch Health Companies' EBITDA rose 9465.41% to $619.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 billion, marking a year-over-year increase of 4051.85%. This contributed to the annual value of $1.5 billion for FY2024, which is 6054.0% up from last year.
  • Latest data reveals that Bausch Health Companies reported EBITDA of $619.0 million as of Q3 2025, which was up 9465.41% from $444.0 million recorded in Q2 2025.
  • Bausch Health Companies' 5-year EBITDA high stood at $619.0 million for Q3 2025, and its period low was -$270.0 million during Q2 2021.
  • For the 5-year period, Bausch Health Companies' EBITDA averaged around $250.1 million, with its median value being $285.0 million (2022).
  • The largest annual percentage gain for Bausch Health Companies' EBITDA in the last 5 years was 744000.0% (2021), contrasted with its biggest fall of 90000.0% (2021).
  • Quarter analysis of 5 years shows Bausch Health Companies' EBITDA stood at $367.0 million in 2021, then tumbled by 164.31% to -$236.0 million in 2022, then soared by 253.39% to $362.0 million in 2023, then skyrocketed by 54.14% to $558.0 million in 2024, then grew by 10.93% to $619.0 million in 2025.
  • Its last three reported values are $619.0 million in Q3 2025, $444.0 million for Q2 2025, and $276.0 million during Q1 2025.